Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.

Transl Androl Urol · 2017 · PMC5760386 · PMID 29354492

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantP=0.050actually significant

Only the DFS benefit associated with the use of NAC was borderline significant (HR =0;83; 95% CI, 0.68–1.00; P=0.050).

also in 11,409 other papers

did not reach statistical significanceno p-value reported

However, GC/carboplatin was associated with an OS benefit (HR =1.26; 95% CI, 1.01–1.57), which did not reach statistical significance after excluding carboplatin patients (HR =1.31; 95% CI, 0.99–1.74).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.